Cancer Signaling & Tumor Biology Antibodies

Cancer Signaling & Tumor Biology Antibodies cover targets involved in growth control, survival pathways, angiogenesis, invasion, epithelial-mesenchymal transition, metastasis, immune interaction, and tumor microenvironment biology. Cancer signaling networks integrate extracellular cues with transcriptional, metabolic, and cytoskeletal changes that shape malignant cell behavior.

Antibodies in this group support analysis of pathway nodes and cellular markers that explain how tumors grow, adapt, spread, and interact with surrounding tissue. They are relevant for studies of cell line models, xenografts, clinical research samples, and mechanistic experiments connecting signaling changes with cancer-associated phenotypes.